
The Wall Street Journal @WSJ
Digital health startups are racing to cash in on booming demand for diabetes drugs that are effective for weight loss, but some of the companies are advertising and prescribing drugs like Ozempic and Wegovy to people who aren’t overweight https://t.co/CRXZeU0VLK — PolitiTweet.org